Pembrolizumab vs Trastuzumab

## Pembrolizumab vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Trastuzumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Pembrolizumab — Antibody; Trastuzumab — Antibody.